Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 207Neoplasms 130Polycystic Ovary Syndrome 107Carcinoma, Hepatocellular 82Colorectal Neoplasms 77Prostatic Neoplasms 70Stomach Neoplasms 55Lung Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 41Pain, Postoperative 41Head and Neck Neoplasms 38Pain 37Liver Neoplasms 36Leukemia, Myeloid, Acute 32Leiomyoma 32Keratosis, Actinic 31Colonic Neoplasms 31Recurrence 30Neoplasm Metastasis 29Multiple Myeloma 28Infertility 28Brain Neoplasms 28Uterine Cervical Neoplasms 26Urinary Bladder Neoplasms 24Ovarian Neoplasms 24Lymphoma 24Esophageal Neoplasms 23Obesity 22

Interventions

Tumor Necrosis Factor Inhibitors 1Etanercept 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Spondylarthritis × Clear all
NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase 4 Completed
31 enrolled

Spondylarthritis

NCT02492217 2020-11-03

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Universidade Nova de Lisboa

Phase 4 Completed
69 enrolled

Spondylitis, Ankylosing, Spondylarthritis

NCT02364479 2019-12-19

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Sun Yat-sen University

Phase 4 Completed
150 enrolled

Recurrence, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡